Q2 2019 Dare Bioscience Inc Earnings Call Transcript
Welcome to the conference call hosted by Daré Bioscience to discuss financial results for the quarter ended June 30, 2019, and to provide a general business update. This call is being recorded. My name is Joelle, and I'll be your operator today.
With us today are Sabrina Martucci Johnson, Daré's President and Chief Executive Officer; Lisa Walters-Hoffert, Daré's Chief Financial Officer; Dr. Christine Mauck, Daré's Medical Director; and Dr. David Friend, Daré's Chief Scientific Officer.
Ms. Johnson, please proceed.
© -
Thank you, and welcome to our financial results and business update call for Daré Bioscience. It's a pleasure to have the opportunity to talk about our second quarter results and company highlights as well as our upcoming milestones for the remainder of 2019 and 2020.
Before we begin, I'd like to remind you that today's discussion will include forward-looking statements within the meaning of federal
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
